Hardman & Co Investor Forum 26th February 2019

Last week we were delighted to host our 15th Investor Forum at the offices of DAC Beachcroft. We welcomed 4 interesting companies to present to an audience of 60 sophisticated investors. The audience had the opportunity to learn more about investing in clean energy, a dividend paying gold miner, and two distinct health care companies at different commercial stages.

Click to view all articles for the EPIC: , ,
Or click to view the full company profile:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Hardman & Co

More articles like this

Hardman & Co

Shield Therapeutics: Accrufer momentum building

Shield Therapeutics plc (LON:STX) is a commercial-stage pharma company delivering specialty products that address patients’ unmet medical needs, with an initial focus on iron deficiency (ID). Following launch of Accrufer® in the US, in July 2021, the initial challenge

Hardman & Co

Shield Therapeutics: PBMs have bought in to Accrufer

Shield Therapeutics plc (LON:STX) is a commercial-stage pharma company delivering specialty products that address patients’ unmet medical needs, with an initial focus on iron deficiency (ID). Following the US launch of Accrufer® in July 2021, the initial challenge

Hardman & Co

Shield Therapeutics: Focused on US market penetration

Shield Therapeutics plc (LON:STX) is a commercial-stage pharmaceutical company delivering specialty products that address patients’ unmet medical needs, with an initial focus on treating iron deficiency (ID). Accrufer® has just been launched in the US by Shield, where

Hardman & Co

Shield Therapeutics: Accrufer® launch on schedule

Shield Therapeutics plc (LON:STX) is a commercial-stage pharmaceutical company delivering specialty products that address patients’ unmet medical needs, with an initial focus on treating iron deficiency (ID). Feraccru®/Accrufer® has been approved by the regulators in both Europe and

Gresham House plc

Gresham House Energy Storage Fund NAV up 74% to £358.9m

Gresham House Energy Storage Fund plc (LON:GRID), the UK’s largest utility-scale battery energy storage fund, has announced its second set of annual results since the IPO in November 2018. This covers the 12 months ended 31 December 2020

Gresham House plc

Gresham House strengthens Institutional Business team

Gresham House plc, the specialist alternative asset manager, has appointed James Lindsay as Head of Institutional Business. James joins from MFS Investment Management where he was Managing Director and Head of Sales, leading its UK institutional sales team

Gresham House plc

Gresham House Ventures invests £2.25m into Metrion Biosciences

Gresham House Ventures – a growth equity investor specialised in software and digitally driven businesses in the healthcare, consumer and services sectors – has invested £2.25m into Metrion Biosciences, a contract research organisation (CRO) catering to the drug

Gresham House plc

Gresham House AGM to be held Wednesday 12 May 2021

Gresham House plc (LON:GHE), the specialist alternative asset manager, has announced that it has published its Report and Accounts for the year ended 31 December 2020 and Notice of Annual General Meeting on the ‘Key Documents’ section of its website https://greshamhouse.com/gresham-house-plc   Copies

Gresham House plc

Blending home and office working a priority for 2021

Fund managers must manage a seamless integration between office and home working in order to avoid damaging silos. They should also adopt agile methodologies used in the technology market in order to speed up their operations and cope

Gresham House plc

Gresham House picks Head of Institutional Business

James Lindsay joined alternative money manager Gresham House as head of institutional business, a spokeswoman confirmed. She did not say whether the position is new or a replacement. Mr. Lindsay is responsible for the strategic development and further expansion

Gresham House plc

Are UK timber prices set to rise in 2021?

As the world focuses on the post COVID-19 economic recovery, the construction and home-building industries are benefitting from renewed activity. While that bodes well for global timber prices in 2021 and beyond, there are specific reasons to be

No more posts to show